/Investor DB

Access Industries — 2020 Investments

2 investments dated 2020 · listed companies and verified rows first · show all

Day One Biopharmaceuticalsdayonebio.comin𝕏Series A · May 2020 · $60M

Day One is a biopharmaceutical company that develops first- or best-in-class targeted medicines for children and adults with life-threatening diseases, with a focus on cancers such as pediatric brain tumors.

BiotechHealthtechSouth San Francisco, US

Jeremy Bender(Executive Officer, Director)

BoardMichael Gladstone(Director)inDerek DiRocco(Director)inJulie Papanek Grant(Director)inJohn Josey(Director)inDaniel Becker(Director)

Co-investorsAccess BiotechnologyAtlas VentureCanaan PartnersViking GlobalRA CapitalThe Column Group

Sisensesisense.comin𝕏Jan 2020

Sisense provides embedded analytics software that enables teams to integrate data visualization and insights into business applications.

AI & Machine LearningData & InfrastructureEnterprise SoftwareSaaSNew York, US

Ariel Katz(Chief Executive Officer)inAmir Orad(Executive Officer, Director)inTodd Sloan(Executive Officer)inAdi Azaria(Founder)Aviad Harell(Founder)Elad Israeli(Founder)

Co-investorsBattery VenturesBessemer Venture PartnersInsight PartnersAUTHENTIC VENTURESClaltechFounders Circle Capital+10 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.